Australia markets closed

Chemomab Therapeutics Ltd. (CMMB)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.9124-0.0406 (-4.26%)
At close: 04:00PM EDT
0.8200 -0.10 (-10.87%)
Pre-market: 06:01AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-19,336
-24,221
-27,646
-12,478
-5,951
Depreciation & amortisation
-
67
58
34
24
Stock-based compensation
-
1,491
3,211
2,019
130
Change in working capital
-
-948
4,007
-1,949
555
Accounts payable
-
-1,172
352
1,175
68
Other working capital
-
-23,614
-20,438
-12,613
-5,280
Net cash provided by operating activities
-
-23,611
-20,370
-12,374
-5,242
Cash flows from investing activities
Investments in property, plant and equipment
-
-3
-68
-239
-38
Purchases of investments
-
-
-
-45,951
-24
Sales/maturities of investments
-
-
19,601
-
-
Other investing activities
-
15,882
19,601
-44,951
-
Net cash used for investing activities
-
15,879
19,533
-45,186
-62
Cash flows from financing activities
Common stock issued
-
3,504
267
58,637
3,500
Common stock repurchased
-
0
-1,218
0
-
Other financing activities
-
-
-
2,427
-
Net cash used provided by (used for) financing activities
-
3,504
-808
61,074
4,750
Net change in cash
-
-4,228
-1,645
3,514
-554
Cash at beginning of period
-
13,596
15,241
11,727
12,281
Cash at end of period
-
9,368
13,596
15,241
11,727
Free cash flow
Operating cash flow
-
-23,611
-20,370
-12,374
-5,242
Capital expenditure
-
-3
-68
-239
-38
Free cash flow
-
-23,614
-20,438
-12,613
-5,280